Actively Recruiting
N-Care Project Using Advanced Genome Sequencing to Diagnose Genetic Diseases in Critically Ill Infants Under 18 Months
Led by National Taiwan University Hospital · Updated on 2025-02-20
70
Participants Needed
1
Research Sites
365 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to use third-generation genome sequencing to quickly diagnose genetic diseases in critically ill infants and young children under 18 months old. The study is a multinational collaboration in the Asian-Pacific region focused on achieving early diagnosis to enable targeted treatment. Participants are critically ill children admitted to intensive care units who show signs suggesting a genetic cause for their condition. Participants will undergo a genetic study using nanopore sequencing technology, which completes long-read genome sequencing within 8 to 11 days. This method analyzes various genetic variations, including single nucleotide variants, small insertions or deletions, and structural changes. Only a small amount of blood 3-5cc is drawn once for testing. The goal is to improve diagnostic accuracy to support personalized care and treatment in intensive care settings. During the study, researchers will collect blood samples and genetic data to evaluate the positive yield rate of the sequencing within 9 days after enrollment. Participants are monitored in the ICU with their clinical information recorded. This observational study involves consented infants under 18 months and focuses on genetic diagnosis without intervention. The total duration and follow-up depend on clinical care needs and data collection timelines.
CONDITIONS
Brief Title
N-Care Project: Enhancing Asian-Pacific Collaboration
Research Team
N
Ni-Chung Lee, MDPhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here